Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | 4 | SCGF-b | 139.0 | 67 | ||||
N2645 | 4 | SCGF-b | 174.0 | 51 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | SCGF-b | 110.0 | 52 | ||||
RA2708 | 4 | SCGF-b | 99.0 | 53 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 204.0 | 57 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 129.0 | 63 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 125.0 | 93 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 120.0 | 75 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 108.0 | 55 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 114.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 154.0 | 83 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 152.0 | 73 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 137.0 | 63 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 153.5 | 70 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 120.0 | 57 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 121.0 | 65 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 175.0 | 70 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 173.5 | 62 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 155.0 | 90 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 151.0 | 69 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 122.0 | 77 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 121.0 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 170.5 | 72 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 165.0 | 65 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 236.0 | 63 |